Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|October 7, 2004
Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled studyGili Kenet, Dalia Waldman, Aharon Lubetsky, et al.
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Infectious Diseases and Therapy|December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter StudyHovav Azuly, Tali Shafat, Daniel Grupel, et al.
Women'S Health (London, England)|July 28, 2011
Low-molecular-weight heparin in women with repeated implantation failureCorrado Lodigiani, Pierpaolo Di Micco, Paola Ferrazzi, et al.
The Lancet. Haematology|December 16, 2017
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trialMoshe Mittelman, Uwe Platzbecker, Boris Afanasyev, et al.
Cell Death & Disease|April 7, 2017
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionShrey Kohli, Juliane Hoffmann, Franziska Lochmann, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
The Lancet. Haematology|January 16, 2019
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a studyAnas Younes, Joshua Brody, Cecilia Carpio, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
The Lancet. Haematology|August 30, 2016
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE studyMarjolein P A Brekelmans, Walter Ageno, Ludo F Beenen, et al.
Pageof 27